The Surveillance and Health Equity Science (SHES) Department is an intramural research program of the American Cancer Society (ACS). Our staff includes world-renowned epidemiologists and health scientists, and we're among the most comprehensive cancer surveillance, health services, and disparities research groups worldwide.
Epidemiologists and health economists in the SHES department publish nearly 100 peer-reviewed journal articles a year in addition to the ACS Cancer Facts & Figures reports.
This team provides recent prevalence estimates and trends for cancer-related vaccination uptakes, cancer screening test use, and major cancer risk factors including:
Health disparities can affect every step of cancer care—from prevention and screening to the quality of life after cancer treatment.
The ACS believes everyone should have a fair and just opportunity to prevent, find, treat, and survive cancer. That belief guides the SHES department, Cancer Disparities Research team to conduct and support studies to improve the understanding of cancer inequalities and to create strategies for overcoming them.
This team's goal is to examine the economic burden of cancer and the influence of health policies and systems on health equity for cancer prevention, early detection, treatment and supportive services, and palliative care.
This team studies the factors that predict the initiation and cessation of tobacco use by tracking the use of tobacco products (including e-cigarettes and other novel tobacco products) in adults and adolescents.
Our study of public policies and tobacco industry activities, through the lens of disparities research, provides evidence that helps support the ACS and ACS CAN’s tobacco control advocacy programs and campaigns at the federal, state, and local levels.
The goal of the Surveillance & Health Equity Science (SHES) department is to conduct interdisciplinary, impactful research and disseminate information on cancer occurrence, prevention, early detection, treatment, survivorship, and economic burden to inform delivery of cancer care and cancer prevention and control nationally and globally in support of the ACS mission “to save lives, celebrate lives, and lead the fight for a world without cancer.”
Specific objectives in support of this goal are to:
Publish high quality educational publications, including the ACS Cancer Facts & Figures reports.
Monitor progress and identify emerging patterns and inequalities across the cancer control continuum—prevention, screening, occurrence, treatment, survivorship, and mortality.
Estimate the contribution of individual, social, institutional, and health system determinants of health on cancer disparities.
Assess the application and effects of health policies, cancer control programs, and guidelines on: a) access to, and receipt of, cancer care, and b) the economic burden and outcomes of cancer control efforts from prevention through mortality.
Create scientific evidence to support and promote ACS and American Cancer Society Cancer Action Network (ACS CAN) campaigns, advocacy efforts, and national roundtables, including their actions to improve access to cancer care and influence federal, state, and local tobacco-control measures.
Advance research in cancer prevention, surveillance, health services, and disparities across the cancer care continuum via scientific publications, conference participation, staff development, and interdisciplinary collaborations with both internal and external partners.
The SHES department is led by Ahmedin Jemal, DVM, PhD, and staffed by more than 20 scientists.
Ongoing and systematic collection, analysis, interpretation, and reporting of cancer data about the new cancer cases, extent of disease, use of screening tests, treatment, survival, and death.
Its goal is to use data to guide public health policy and action, such as the distribution of health care resources.